Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 7 | 2024 | 85 | 2.870 |
Why?
|
| Brain Diseases | 5 | 2020 | 71 | 1.740 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 2024 | 93 | 1.690 |
Why?
|
| Intracranial Aneurysm | 5 | 2021 | 345 | 1.120 |
Why?
|
| Consciousness | 2 | 2023 | 12 | 0.950 |
Why?
|
| Cerebral Infarction | 1 | 2024 | 76 | 0.880 |
Why?
|
| Anticoagulants | 2 | 2018 | 480 | 0.870 |
Why?
|
| Critical Care | 4 | 2021 | 399 | 0.830 |
Why?
|
| Skilled Nursing Facilities | 1 | 2023 | 83 | 0.810 |
Why?
|
| Cholesterol | 1 | 2024 | 253 | 0.800 |
Why?
|
| Neurosurgical Procedures | 4 | 2018 | 95 | 0.750 |
Why?
|
| Brain Death | 4 | 2022 | 16 | 0.730 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 3 | 2024 | 12 | 0.700 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2020 | 20 | 0.700 |
Why?
|
| Intracranial Hypotension | 2 | 2018 | 7 | 0.700 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 10 | 0.680 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 21 | 0.680 |
Why?
|
| Stroke | 4 | 2022 | 1128 | 0.640 |
Why?
|
| Basilar Artery | 3 | 2021 | 30 | 0.630 |
Why?
|
| Brain Stem Infarctions | 2 | 2009 | 4 | 0.620 |
Why?
|
| Neurologists | 1 | 2018 | 7 | 0.600 |
Why?
|
| Hemorrhage | 2 | 2018 | 260 | 0.590 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2024 | 119 | 0.580 |
Why?
|
| Blood Coagulation Factors | 1 | 2018 | 13 | 0.580 |
Why?
|
| Plasma | 1 | 2018 | 35 | 0.580 |
Why?
|
| Humans | 45 | 2024 | 59428 | 0.570 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2016 | 70 | 0.560 |
Why?
|
| Brain Edema | 5 | 2012 | 31 | 0.560 |
Why?
|
| Warfarin | 1 | 2018 | 105 | 0.550 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 42 | 0.510 |
Why?
|
| Brain | 6 | 2017 | 1488 | 0.500 |
Why?
|
| Coma | 2 | 2018 | 13 | 0.470 |
Why?
|
| Serotonin Syndrome | 1 | 2013 | 9 | 0.430 |
Why?
|
| Serotonin Antagonists | 1 | 2013 | 30 | 0.430 |
Why?
|
| Clozapine | 1 | 2013 | 32 | 0.430 |
Why?
|
| Citalopram | 1 | 2013 | 19 | 0.430 |
Why?
|
| Aged, 80 and over | 10 | 2018 | 5126 | 0.420 |
Why?
|
| Neurology | 1 | 2013 | 33 | 0.410 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2013 | 1514 | 0.410 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2018 | 2053 | 0.410 |
Why?
|
| Brain Ischemia | 2 | 2016 | 399 | 0.410 |
Why?
|
| Embolization, Therapeutic | 2 | 2021 | 308 | 0.400 |
Why?
|
| Registries | 1 | 2016 | 801 | 0.400 |
Why?
|
| Vasospasm, Intracranial | 1 | 2011 | 25 | 0.380 |
Why?
|
| Tegmentum Mesencephali | 2 | 2009 | 6 | 0.380 |
Why?
|
| Middle Aged | 14 | 2021 | 16330 | 0.370 |
Why?
|
| Hemodynamics | 1 | 2011 | 230 | 0.350 |
Why?
|
| Persistent Vegetative State | 2 | 2010 | 2 | 0.350 |
Why?
|
| Ischemic Attack, Transient | 1 | 2011 | 90 | 0.340 |
Why?
|
| Female | 22 | 2021 | 30753 | 0.330 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2009 | 2 | 0.330 |
Why?
|
| Anisocoria | 1 | 2009 | 3 | 0.320 |
Why?
|
| Benzodiazepines | 2 | 2024 | 94 | 0.320 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2009 | 23 | 0.320 |
Why?
|
| Quality of Health Care | 1 | 2013 | 514 | 0.310 |
Why?
|
| Hyperglycemia | 1 | 2009 | 98 | 0.300 |
Why?
|
| Mediastinal Emphysema | 1 | 2008 | 6 | 0.300 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2008 | 13 | 0.300 |
Why?
|
| Pupil Disorders | 1 | 2008 | 4 | 0.290 |
Why?
|
| Aged | 11 | 2021 | 13423 | 0.290 |
Why?
|
| Heart Arrest | 1 | 2010 | 161 | 0.290 |
Why?
|
| Pneumothorax | 1 | 2008 | 49 | 0.280 |
Why?
|
| Male | 17 | 2021 | 27773 | 0.280 |
Why?
|
| Biopsy | 1 | 2008 | 410 | 0.270 |
Why?
|
| Treatment Outcome | 9 | 2018 | 5287 | 0.270 |
Why?
|
| Retrospective Studies | 7 | 2022 | 6077 | 0.260 |
Why?
|
| Leukoencephalitis, Acute Hemorrhagic | 2 | 2020 | 3 | 0.260 |
Why?
|
| Coronary Artery Bypass | 1 | 2008 | 275 | 0.250 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 154 | 0.240 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 274 | 0.230 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 863 | 0.230 |
Why?
|
| Time Factors | 3 | 2024 | 3620 | 0.220 |
Why?
|
| Adult | 11 | 2021 | 15694 | 0.210 |
Why?
|
| Cohort Studies | 4 | 2013 | 2376 | 0.200 |
Why?
|
| Neurologic Examination | 3 | 2011 | 52 | 0.190 |
Why?
|
| Central Nervous System Infections | 1 | 2021 | 6 | 0.190 |
Why?
|
| Movement Disorders | 1 | 2021 | 22 | 0.180 |
Why?
|
| Hernia | 2 | 2012 | 15 | 0.180 |
Why?
|
| Heart Transplantation | 1 | 2022 | 162 | 0.170 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2021 | 89 | 0.170 |
Why?
|
| Guideline Adherence | 1 | 2022 | 295 | 0.170 |
Why?
|
| Sodium | 2 | 2010 | 60 | 0.160 |
Why?
|
| Brain Stem | 2 | 2010 | 28 | 0.160 |
Why?
|
| Aneurysm, Ruptured | 2 | 2012 | 71 | 0.160 |
Why?
|
| Risk Factors | 4 | 2011 | 4990 | 0.160 |
Why?
|
| Age Distribution | 2 | 2011 | 249 | 0.160 |
Why?
|
| Liver Transplantation | 1 | 2021 | 207 | 0.160 |
Why?
|
| Intensive Care Units | 2 | 2013 | 430 | 0.150 |
Why?
|
| Hematoma, Subdural | 1 | 2018 | 9 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 2 | 2010 | 174 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 166 | 0.150 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 32 | 0.150 |
Why?
|
| Professional Role | 1 | 2018 | 39 | 0.140 |
Why?
|
| Myelitis | 1 | 2017 | 3 | 0.140 |
Why?
|
| Meningoencephalitis | 1 | 2017 | 7 | 0.140 |
Why?
|
| Pharmaceutical Services | 1 | 2018 | 31 | 0.140 |
Why?
|
| Zika Virus | 1 | 2017 | 32 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 192 | 0.140 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 32 | 0.140 |
Why?
|
| Hematoma | 1 | 2017 | 68 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 1028 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 205 | 0.140 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 110 | 0.130 |
Why?
|
| Pharmacists | 1 | 2018 | 123 | 0.130 |
Why?
|
| Emergency Service, Hospital | 2 | 2016 | 1022 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2018 | 526 | 0.120 |
Why?
|
| Cerebral Angiography | 3 | 2012 | 280 | 0.120 |
Why?
|
| Reference Values | 2 | 2021 | 326 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 617 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2018 | 329 | 0.120 |
Why?
|
| Monitoring, Physiologic | 2 | 2013 | 149 | 0.120 |
Why?
|
| Seizures | 2 | 2012 | 113 | 0.110 |
Why?
|
| Acute Disease | 2 | 2021 | 659 | 0.110 |
Why?
|
| Hiccup | 1 | 2013 | 3 | 0.110 |
Why?
|
| Cyproheptadine | 1 | 2013 | 2 | 0.110 |
Why?
|
| Medulla Oblongata | 1 | 2013 | 7 | 0.110 |
Why?
|
| Eclampsia | 1 | 2012 | 3 | 0.100 |
Why?
|
| Pons | 2 | 2010 | 15 | 0.100 |
Why?
|
| Brain Infarction | 1 | 2012 | 19 | 0.100 |
Why?
|
| Thalamus | 2 | 2010 | 64 | 0.100 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2013 | 74 | 0.100 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2011 | 3 | 0.100 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2011 | 7 | 0.100 |
Why?
|
| Dominance, Cerebral | 1 | 2011 | 32 | 0.100 |
Why?
|
| Paresis | 1 | 2011 | 15 | 0.100 |
Why?
|
| Intracranial Hypertension | 1 | 2011 | 10 | 0.100 |
Why?
|
| Pineal Gland | 1 | 2011 | 26 | 0.100 |
Why?
|
| Multiple Trauma | 1 | 2011 | 27 | 0.090 |
Why?
|
| Recovery of Function | 2 | 2013 | 271 | 0.090 |
Why?
|
| Laparotomy | 1 | 2011 | 47 | 0.090 |
Why?
|
| Middle Cerebral Artery | 1 | 2011 | 46 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 108 | 0.090 |
Why?
|
| Prognosis | 2 | 2022 | 1597 | 0.090 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 61 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 145 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2012 | 184 | 0.090 |
Why?
|
| Isoflurane | 1 | 2010 | 17 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2011 | 244 | 0.090 |
Why?
|
| Status Epilepticus | 1 | 2010 | 21 | 0.090 |
Why?
|
| Natriuretic Agents | 1 | 2010 | 1 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2011 | 167 | 0.090 |
Why?
|
| Water-Electrolyte Balance | 1 | 2010 | 17 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 148 | 0.080 |
Why?
|
| Hyponatremia | 1 | 2010 | 13 | 0.080 |
Why?
|
| Hypertension | 2 | 2012 | 570 | 0.080 |
Why?
|
| Anticonvulsants | 1 | 2010 | 88 | 0.080 |
Why?
|
| Recurrence | 1 | 2011 | 603 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2011 | 135 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 396 | 0.080 |
Why?
|
| Disease Progression | 3 | 2010 | 1119 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 275 | 0.080 |
Why?
|
| Blood Urea Nitrogen | 1 | 2009 | 9 | 0.080 |
Why?
|
| Reflex, Pupillary | 1 | 2009 | 2 | 0.080 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2009 | 5 | 0.080 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2009 | 17 | 0.080 |
Why?
|
| Length of Stay | 1 | 2013 | 779 | 0.080 |
Why?
|
| Confusion | 1 | 2009 | 16 | 0.080 |
Why?
|
| Ataxia | 1 | 2009 | 21 | 0.080 |
Why?
|
| Mesencephalon | 1 | 2009 | 25 | 0.080 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 674 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2011 | 496 | 0.080 |
Why?
|
| Rupture, Spontaneous | 1 | 2009 | 22 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 208 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 66 | 0.080 |
Why?
|
| Surgical Instruments | 1 | 2009 | 41 | 0.080 |
Why?
|
| Observer Variation | 1 | 2008 | 205 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2009 | 201 | 0.070 |
Why?
|
| Apnea | 1 | 2008 | 30 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2009 | 215 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2008 | 178 | 0.070 |
Why?
|
| Comorbidity | 1 | 2011 | 1078 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 164 | 0.070 |
Why?
|
| Incidence | 1 | 2011 | 1239 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 495 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2009 | 461 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2013 | 1204 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 903 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 243 | 0.060 |
Why?
|
| Insulin | 1 | 2009 | 673 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 805 | 0.060 |
Why?
|
| Clonidine | 1 | 2024 | 24 | 0.060 |
Why?
|
| Amines | 1 | 2024 | 29 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2024 | 72 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1482 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 2338 | 0.050 |
Why?
|
| Checklist | 1 | 2022 | 72 | 0.050 |
Why?
|
| Glasgow Coma Scale | 2 | 2012 | 43 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2008 | 1926 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2022 | 143 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 2021 | 22 | 0.050 |
Why?
|
| Living Donors | 1 | 2021 | 72 | 0.050 |
Why?
|
| Alcoholism | 1 | 2024 | 310 | 0.040 |
Why?
|
| Graft Survival | 1 | 2022 | 290 | 0.040 |
Why?
|
| Emergencies | 1 | 2021 | 110 | 0.040 |
Why?
|
| Animals | 1 | 2018 | 19660 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 178 | 0.040 |
Why?
|
| Age Factors | 1 | 2022 | 1505 | 0.040 |
Why?
|
| Stents | 1 | 2021 | 461 | 0.040 |
Why?
|
| Iodine | 1 | 2017 | 19 | 0.040 |
Why?
|
| Calibration | 1 | 2017 | 67 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 5843 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 217 | 0.030 |
Why?
|
| Physicians | 1 | 2021 | 440 | 0.030 |
Why?
|
| Hospitalization | 1 | 2022 | 1292 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 1097 | 0.030 |
Why?
|
| Software | 1 | 2017 | 366 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 2013 | 20 | 0.030 |
Why?
|
| Telemetry | 1 | 2013 | 19 | 0.030 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2013 | 40 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2517 | 0.030 |
Why?
|
| Hematoma, Subdural, Intracranial | 1 | 2011 | 2 | 0.020 |
Why?
|
| Mannitol | 1 | 2011 | 14 | 0.020 |
Why?
|
| Ventriculostomy | 1 | 2011 | 5 | 0.020 |
Why?
|
| Glasgow Outcome Scale | 1 | 2011 | 17 | 0.020 |
Why?
|
| Intracranial Pressure | 1 | 2011 | 19 | 0.020 |
Why?
|
| APACHE | 1 | 2011 | 47 | 0.020 |
Why?
|
| Drainage | 1 | 2012 | 150 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 104 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 354 | 0.020 |
Why?
|
| Trauma Centers | 1 | 2011 | 114 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2012 | 187 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 148 | 0.020 |
Why?
|
| Hypovolemia | 1 | 2010 | 16 | 0.020 |
Why?
|
| Natriuretic Peptides | 1 | 2010 | 6 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1054 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2010 | 21 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 210 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 516 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 34 | 0.020 |
Why?
|
| Cerebellum | 1 | 2010 | 91 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 284 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 289 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 116 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2012 | 251 | 0.020 |
Why?
|
| Necrosis | 1 | 2010 | 140 | 0.020 |
Why?
|
| United States | 1 | 2022 | 7429 | 0.020 |
Why?
|
| Kidney | 1 | 2010 | 414 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 932 | 0.020 |
Why?
|
| Critical Illness | 1 | 2010 | 329 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 3069 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 2214 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2010 | 1794 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2008 | 1286 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 4273 | 0.010 |
Why?
|